Gepotidacin

undefined

CAS Number1075236-89-3
Molecular FormulaC24H28N6O3
Molecular Weight448.5
InChI KeyPZFAZQUREQIODZ-LJQANCHMSA-N
LogP0.1
Synonyms
  • Gepotidacin
  • 1075236-89-3
  • GSK-2140944
  • Gepotidacina
  • Gepotidacine
  • DVF0PR037D
  • DTXSID501028208
  • (3R)-3-[[4-(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.04,12]dodeca-6,8(12),9-triene-5,11-dione
  • 3H,8H-2a,5,8a-Triazaacenaphthylene-3,8-dione, 2-((4-(((3,4-dihydro-2H-pyrano(2,3-C)pyridin-6-yl)methyl)amino)-1-piperidinyl)methyl)-1,2-dihydro-, (2R)-
  • gepotidacinum
  • (2R)-2-((4-(((3,4-Dihydro-2H-pyrano(2,3-c)pyridin-6-yl)methyl)amino)-1-piperidinyl)methyl)-1,2-dihydro-3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione
  • (2R)-2-[[4-[[(3,4-Dihydro-2H-pyrano[2,3-c]pyridin-6-yl)methyl]amino]-1-piperidinyl]methyl]-1,2-dihydro-3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione
  • (3R)-3-((4-(3,4-dihydro-2H-pyrano(2,3-c)pyridin-6-ylmethylamino)piperidin-1-yl)methyl)-1,4,7-triazatricyclo(6.3.1.04,12)dodeca-6,8(12),9-triene-5,11-dione
  • 3H,8H-2a,5,8a-Triazaacenaphthylene-3,8-dione, 2-[[4-[[(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-yl)methyl]amino]-1-piperidinyl]methyl]-1,2-dihydro-, (2R)-
  • RefChem:639850
  • DTXCID501513790
  • (3R)-3-((4-(((2H,3H,4H-pyrano(2,3-c)pyridin-6-yl)methyl)amino)piperidin-1-yl)methyl)-1,4,7-triazatricyclo(6.3.1.0^(4,12))dodeca-6,8(12),9-triene-5,11-dione
  • GSK2140944
  • GSK 2140944
  • Blujepa
  • (2R)-2-[(4-{[(3,4-dihydro-2H-pyrano[2,3-c]pyridin- 6-yl)methyl]amino}piperidin-1-yl)methyl]-1,2-dihydro- 3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione
  • (R)-2-((4-(((3,4-Dihydro-2H-Pyrano[2,3-C]Pyridin-6-Yl)Methyl)Amino)Piperidin-1-Yl)Methyl)-1,2-Dihydro-3H,8H-2A,5,8A-Triazaacenaphthylene-3,8-Dione
  • (3~{R})-3-[[4-(3,4-dihydro-2~{H}-pyrano[2,3-c]pyridin-6-ylmethylamino)piperidin-1-yl]methyl]-1,4,7-triazatricyclo[6.3.1.0^{4,12}]dodeca-6,8(12),9-triene-5,11-dione
  • Gepotidacin [USAN:INN]
  • UNII-DVF0PR037D
  • JHN
  • Gepotidacin [INN]
  • Gepotidacin (USAN/INN)
  • GEPOTIDACIN [USAN]
  • GEPOTIDACIN [WHO-DD]
  • orb1709615
  • SCHEMBL3332319
  • CHEMBL3317856
  • SCHEMBL29379990
  • GTPL10817
  • YQF2539
  • C24H28N6O3
  • GLXC-21974
  • ATB23689
  • EX-A7794
  • BDBM50050549
  • GSK 2140944E
  • MFCD27987926
  • AKOS032946511
  • CS-6531
  • DB12134
  • EBC-111025
  • AC-38196
  • BP-44436
  • DA-73703
  • HY-16742
  • MS-28128
  • SY038432
  • NS00073409
  • D10878
  • G14345
  • Q19597285
  • (3R)-3-({4-[({2H,3H,4H-pyrano[2,3-c]pyridin-6-yl}methyl)amino]piperidin-1-yl}methyl)-1,4,7-triazatricyclo[6.3.1.0,4,12]dodeca-6,8(12),9-triene-5,11-dione
  • (3R)-3-[[4-(3,4-dihydro-2H-pyrano[2,3-c]pyridin-6-ylmethylamino)-1-piperidyl]methyl]-1,4,7-triazatricyclo[6.3.1.04,12]dodeca-6,8(12),9-triene-5,11-dione
  • (R)-2-[[4-[[[3,4-Dihydro-2H-pyrano[2,3-c]pyridin-6-yl]methyl]amino]piperidin-1-yl]methyl]-1,2-dihydro-2a,5,8a-triazaacenaphthylene-3,8-dione

Applications:

Uv-Vis Spectrum of Gepotidacin

January 13, 2026
Access the UV-Vis Spectrum SIELC Library
UV-Vis Spectrum of Gepotidacin.

If you are looking for optimized HPLC method to analyze Gepotidacin check our HPLC Applications library

For optimal results in HPLC analysis, it is recommended to measure absorbance at a wavelength that matches the absorption maximum of the compound(s) being analyzed. The UV spectrum shown can assist in selecting an appropriate wavelength for your analysis. Please note that certain mobile phases and buffers may block wavelengths below 230 nm, rendering absorbance measurement at these wavelengths ineffective. If detection below 230 nm is required, it is recommended to use acetonitrile and water as low UV-transparent mobile phases, with phosphoric acid and its salts, sulfuric acid, and TFA as buffers.
For some compounds, the UV-Vis Spectrum is affected by the pH of the mobile phase. The spectra presented here are measured with an acidic mobile phase that has a pH of 3 or lower.

Application Analytes:
Gepotidacin
SIELC Technologies usually develops more than one method for each compound. Therefore, this particular method may not be the best available method from our portfolio for your specific application. Before you decide to implement this method in your research, please send us an email to research@sielc.com so we can ensure you get optimal results for your compound/s of interest.